As scientists and clinicians, we have dedicated our careers to an integrated approach to responding to disease and conditions driving adverse human health. With our understanding of the Microbiome, we have developed patented technology to disrupt the disease cascade of the myriad of diseases and health conditions strongly associated with the Human Microbiome. Scaled Microbiomics has discovered solutions that can be rapidly and cost-effectively developed and deployed to address human health needs- providing diagnostics, prophylactics, and treatments to combat targeted conditions with our patented platform technology. Intercepting microbiome-driven disease and supporting wellness with targeted, passive immunotherapeutics that modulate microbiome-host signaling pathways through rational systems biology-based drug design. As scientists and clinicians, we have dedicated our careers to an integrated approach to responding to disease and conditions driving adverse human health. With our understanding of the Microbiome, we have developed patented technology to disrupt the disease cascade of the myriad of diseases and health conditions strongly associated with the Human Microbiome. Scaled Microbiomics has discovered solutions that can be rapidly and cost-effectively developed and deployed to address human health needs- providing diagnostics, prophylactics, and treatments to combat targeted conditions with our patented platform technology. Intercepting microbiome-driven disease and supporting wellness with targeted, passive immunotherapeutics that modulate microbiome-host signaling pathways through rational systems biology-based drug design. Our expertise lies in driving an antibody approach to Subtractive Microbiomic Therapies. Our innovative approach combines an understood regulatory pathway (antibodies) with exciting new understanding of the microbiome manipulation to allow SMB to rapidly develop diagnostic and therapeutic interventions as an order of magnitude less time and cost. We currently collaborate with ...
View Top Employees from Scaled MicrobiomicsWebsite | http://scaledmicrobiomics.com |
Revenue | $2 million |
Employees | 2 (2 on RocketReach) |
Address | 20140 Scholar Dr, Hagerstown, Maryland 21742, US |
Phone | (585) 857-9237 |
Industry | Business Services General, Business Services |
Competitors | Arrakis Therapeutics, Cavatar, NP Biosciences, TetraGenetics Inc. |
SIC | SIC Code 87 Companies, SIC Code 873 Companies |
NAICS | NAICS Code 541713 Companies, NAICS Code 541 Companies, NAICS Code 54 Companies, NAICS Code 5417 Companies, NAICS Code 54171 Companies |
Looking for a particular Scaled Microbiomics employee's phone or email?
The Scaled Microbiomics annual revenue was $2 million in 2024.
2 people are employed at Scaled Microbiomics.
Scaled Microbiomics is based in Hagerstown, Maryland.
The NAICS codes for Scaled Microbiomics are [541713, 541, 54, 5417, 54171].
The SIC codes for Scaled Microbiomics are [87, 873].